Back to top

Delcath Systems sees positive adjusted EBITDA in FY26

The Company’s financial outlook for fiscal year 2026: Total HEPZATO KIT and CHEMOSAT revenue to range from $104 million to $108 million, reflecting...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Delcath Systems, Inc. (DCTH)